Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,884.86 -436.66 (-0.68%) CMC Crypto 200
1,325.05 +48.08 (+3.77%)
OncoVista Innovative Therapies, Inc. (OVIT)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:28PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 434.89k |
| Enterprise value | 852.92k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 26.09 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.26 |
Trading information
Stock price history
| Beta (5Y monthly) | -42.95 |
| 52-week change 3 | -50.00% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 0.0002 |
| 52-week low 3 | 0.0001 |
| 50-day moving average 3 | 0.0001 |
| 200-day moving average 3 | 0.0001 |
Share statistics
| Avg vol (3-month) 3 | 3.72k |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 23.56M |
| Implied shares outstanding 6 | 5.58B |
| Float 8 | N/A |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1.4749:1 |
| Last split date 3 | 29 Oct 2007 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2014 |
| Most-recent quarter (mrq) | 30 Sept 2015 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -2,357.68% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -3.4M |
| Net income avi to common (ttm) | -3.27M |
| Diluted EPS (ttm) | -0.0000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 61.27k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 479.3k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.01 |
| Book value per share (mrq) | -0.28 |
Cash flow statement
| Operating cash flow (ttm) | -264.36k |
| Levered free cash flow (ttm) | -635.24k |
© 2024 Yahoo. All rights reserved.